Yang Jun, Zhao Xiaofeng, Patel Archana, Potru Rachana, Azizi-Ghannad Sadra, Dolinger Michael, Cao James, Bartholomew Catherine, Mazurkiewicz Joseph, Conti David, Jones David, Huang Yunfei, Zhu Xinjun Cindy
Department of Medicine, Division of Gastroenterology and Hepatology, Albany Medical College, Albany, New York; Center of Cardiovascular Sciences, Albany Medical College, Albany, New York.
Department of Medicine, Division of Gastroenterology and Hepatology, Albany Medical College, Albany, New York.
Gastroenterology. 2015 Jul;149(1):151-62. doi: 10.1053/j.gastro.2015.03.046. Epub 2015 Mar 30.
BACKGROUND & AIMS: The immunosuppressant rapamycin frequently causes noninfectious diarrhea in organ transplant recipients. We investigated the mechanisms of this process.
We performed a retrospective analysis of renal transplant recipients treated with rapamycin from 2003 through 2010 at Albany Medical College, collecting data on serum levels of rapamycin. Levels of the Na+/H+ exchanger 3 (NHE3) were measured in human ileal biopsy specimens from patients who did and did not receive rapamycin (controls), in ileum tissues from rats or mice given rapamycin, and in mice with intestine-specific disruption of mammalian target of rapamycin (Mtor) (mTOR(f/f):Villin-cre mice) or Atg7 (Atg7(flox/flox); Villin-Cre). Exchange activity and intestinal water absorption were measured using a pH-sensitive dye and small intestine perfusion, respectively.
Episodes of noninfectious diarrhea occurred in organ recipients after increases in serum levels of rapamycin. The expression of NHE3 was reduced in the ileal brush border of patients with diarrhea. In rats and mice, continuous administration of low doses of rapamycin reduced levels of NHE3 in intestinal tissues; this effect was not observed in mice with intestinal deletion of ATG7, indicating that autophagy is required for the reduction. Administration of single high doses of rapamycin to mice, to model the spikes in rapamycin levels that occur in patients with severe diarrheal episodes, resulted in reduced phosphorylation of S6 and AKT in ileal tissues, indicating inhibition of the mTOR complex (mTORC1 and mTORC2). The intestines of mice with intestine-specific deletion of mTOR were dilated and contained large amounts of liquid stools; they also had reduced levels of total NHE3 and NHERF1 compared with control mice. We observed a significant reduction in Na(+)/H(+) exchange activity in ileum tissues from these mice.
Rapamycin inhibition of mTOR reduces levels of NHE3 and Na(+)/H(+) exchange activity in intestinal tissues of patients and rodents. This process appears to require the autophagic activity mediated by ATG7. Loss of mTOR regulation of NHE3 could mediate the development of diarrhea in patients undergoing rapamycin therapy.
免疫抑制剂雷帕霉素常导致器官移植受者出现非感染性腹泻。我们对这一过程的机制进行了研究。
我们对2003年至2010年在奥尔巴尼医学院接受雷帕霉素治疗的肾移植受者进行了回顾性分析,收集雷帕霉素血清水平数据。在接受和未接受雷帕霉素治疗的患者(对照组)的人回肠活检标本、给予雷帕霉素的大鼠或小鼠的回肠组织以及肠道特异性敲除雷帕霉素哺乳动物靶点(Mtor)的小鼠(mTOR(f/f):Villin-cre小鼠)或Atg7(Atg7(flox/flox); Villin-Cre)中测量钠氢交换体3(NHE3)的水平。分别使用pH敏感染料和小肠灌注测量交换活性和肠道水吸收。
器官移植受者在雷帕霉素血清水平升高后出现非感染性腹泻发作。腹泻患者回肠刷状缘中NHE3的表达降低。在大鼠和小鼠中,持续给予低剂量雷帕霉素可降低肠道组织中NHE3的水平;在肠道敲除ATG7的小鼠中未观察到这种效应,表明自噬是这种降低所必需的。给小鼠单次给予高剂量雷帕霉素,以模拟严重腹泻发作患者中出现的雷帕霉素水平峰值,导致回肠组织中S6和AKT的磷酸化降低,表明雷帕霉素复合物(mTORC1和mTORC2)受到抑制。肠道特异性敲除mTOR的小鼠肠道扩张,含有大量液体粪便;与对照小鼠相比,它们的总NHE3和NHERF1水平也降低。我们观察到这些小鼠回肠组织中的钠氢交换活性显著降低。
雷帕霉素对mTOR的抑制降低了患者和啮齿动物肠道组织中NHE3的水平和钠氢交换活性。这一过程似乎需要由ATG7介导的自噬活性。mTOR对NHE3调节的丧失可能介导接受雷帕霉素治疗患者腹泻的发生。